alexa Metabolomic Analysis Of A Brain Metastasis Cell Line Of Lung Cancer Origin Revealed Differential Adaptive Responses To Metabolic Stresses | 65260
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

8th International Conference and Exhibition on Metabolomics & Systems Biology

Andrew M Chan, Indy K L Wong and Penelope M Y
Chinese University of Hong Kong, Hong Kong
ScientificTracks Abstracts: Metabolomics
DOI: 10.4172/2153-0769-C1-037
Abstract
Metastatic diseases in lung adenocarcinoma are often associated with poor prognosis. We have previously characterized a brain metastasis cell line of lung cancer origin, A1115, which possessed heightened glycolytic activity when compared with other lung adenocarcinoma cell lines such as, A549, derived from a primary site. A1115 has greater lactate production than A549. Conversely, A549 has a greater oxygen uptake rate that could be effectively blocked by oligomycin. Indeed, the proliferation of A549 was hypersensitive to oligomycin treatment while A1115 was greatly inhibited by glucose deprivation. Western blotting analysis revealed both hexokinase I (HK1) and phosphoenolpyruvate carboxykinase 1 (PCK1) were preferentially expressed in A1115. For energy sensing signaling, AMPK╬▒, which senses cellular AMP level, was phosphorylated in A549 but not in A1115. Indeed, the proliferative capacity of A1115 was drastically reduced by an AMPK activator, AICAR, while A549 was not affected. Metabolite profiles under reduced 1 g/L revealed a 5- to 24-fold increase in metabolites that are linked to purine metabolism (e.g. hypoxanthine, GMP, and adenosine). Treatment with a XOD inhibitor, allopurinol under reduced glucose condition increased cell viability in A1115 at low doses while toxic at high doses. This data suggests that heightened hypoxanthine may be a prosurvival adaptive response in A1115 under nutrient stress conditions. We further selected A1115 sublines that could survive at a low glucose concentration (0.15 g/L). Western blotting analysis revealed a drastic overexpression of PCK1 and PKC2 when compared to parental cells. Transcriptomic analysis was also performed to reveal genes that could play a role in the survival of brain metastatic lung cancer cells under nutrient stresses. Taken together, these results identified multiple vulnerable points in metabolic signaling that could be therapeutic targets for treating metastatic lung cancers.
Biography

Andrew M Chan is currently a Professor and Chief of the Cancer Biology & Experimental Therapeutics Thematic Research Program at the School of Biomedical Sciences of the Chinese University of Hong Kong. He has obtained his PhD degree from the Chester Beatty Laboratory of the Institute of Cancer Research in London. He was a Fogarty International Fellow at the US National Cancer Institute in the Laboratory of Cellular & Molecular Biology. He was a Faculty Member at the Mount Sinai School of Medicine and the Medical College of Wisconsin. His research interest is in the area of cancer cell signaling and mouse models of human cancers with focuses on the PI3-K and Ras-mediated signaling mechanisms in brain, breast and lung cancers.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7